Destination Wealth Management bought a new stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 26,577 shares of the semiconductor company’s stock, valued at approximately $13,113,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Stanley Laman Group Ltd. grew its stake in shares of Synopsys by 542.9% in the 3rd quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock valued at $6,353,000 after purchasing an additional 10,874 shares during the last quarter. Symphony Financial Ltd. Co. raised its stake in shares of Synopsys by 4,780.9% during the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after purchasing an additional 39,395 shares during the last quarter. Empirical Asset Management LLC acquired a new stake in shares of Synopsys during the third quarter worth $773,000. Strategic Advisors LLC lifted its holdings in shares of Synopsys by 76.3% during the third quarter. Strategic Advisors LLC now owns 7,578 shares of the semiconductor company’s stock worth $3,739,000 after purchasing an additional 3,279 shares during the period. Finally, Napean Trading & Investment Co Singapore PTE Ltd grew its position in Synopsys by 17.6% in the 2nd quarter. Napean Trading & Investment Co Singapore PTE Ltd now owns 23,683 shares of the semiconductor company’s stock valued at $12,142,000 after buying an additional 3,544 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of NASDAQ SNPS opened at $412.63 on Monday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The firm has a market capitalization of $79.04 billion, a P/E ratio of 64.07, a PEG ratio of 3.36 and a beta of 1.15. The company’s fifty day moving average is $461.93 and its two-hundred day moving average is $462.67.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on SNPS. JPMorgan Chase & Co. upped their price objective on shares of Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Needham & Company LLC reaffirmed a “buy” rating on shares of Synopsys in a report on Thursday, February 26th. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Wells Fargo & Company cut their price target on shares of Synopsys from $500.00 to $450.00 and set an “equal weight” rating for the company in a report on Thursday, February 26th. Finally, HSBC downgraded shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective for the company. in a research report on Friday, February 20th. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $531.00.
View Our Latest Stock Report on SNPS
Insider Transactions at Synopsys
In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Janet Lee sold 250 shares of Synopsys stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 4,157 shares of company stock valued at $1,945,036. 0.56% of the stock is currently owned by corporate insiders.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
